Self-Directed Biological Transformation Initiative
SBTI
1 other identifier
interventional
115
1 country
1
Brief Summary
It is becoming increasingly recognized in the literature that ancient practices for wellbeing, including meditation, yoga, and specific herbs, can improve health and promote longevity. While studies have documented such effects for a variety of individual practices for wellbeing, few studies have taken a more whole systems approach that is simultaneously inclusive of numerous practices. This intervention study, the "Self-Directed Biological Transformation Initiative", will examine the effects of a comprehensive whole systems approach to wellbeing on key biochemical, physiological, and psychosocial endpoints. Participants randomized to the Perfect Health program at the Chopra Center for Wellbeing will be compared to individuals not taking the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 9, 2014
CompletedFirst Posted
Study publicly available on registry
September 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedDecember 16, 2015
December 1, 2015
5 months
September 9, 2014
December 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in RNA expression
Blood samples will be collected for RNA expression and assayed using standardized methodologies
Assessed pre and post 7 day intervention
Change in cytokine levels
Blood samples will be collected for inflammatory cytokine levels and determined via standardized ELISA methods
Assessed pre and post 7 day intervention
Change in telomerase activity
Blood samples will be collected for PBMC telomerase activity and assayed using standardized methodologies
Assessed pre and post 7 day intervention
Change in neurohormome levels
Blood and saliva samples will be collected for neurohormone levels and be determined via standardized ELISA methods
Assessed pre and post 7 day intervention
Secondary Outcomes (1)
Change in heart rate variability
Assessed pre and post 7 day intervention and one month follow-up
Other Outcomes (4)
Change in quality of life
Assessed pre and post 7 day intervention and one month follow-up
Change in gut microbiome populations
Assessed pre and post 7 day intervention and one month follow-up
Change in mood
Assessed pre and post 7 day intervention and one month follow-up
- +1 more other outcomes
Study Arms (2)
Perfect health course
EXPERIMENTALPerfect health course at the Chopra Center for Wellbeing
Resort group
NO INTERVENTIONResort group at the La Costa resort
Interventions
The Perfect Health course as taught at the Chopra Center for Wellbeing
Eligibility Criteria
You may qualify if:
- Men and women between the ages of 40-80 years
You may not qualify if:
- Self-reported diagnosis of a major medical condition, such as cancer (including those who have received past radiation or chemotherapy treatment), heart disease, autoimmune disease, or diabetes, as these can affect the cell aging system and possibly the ability for telomerase to change in short periods
- Individuals taking antidepressant medication will be excluded since such medication appears to increase telomerase (Wolkowitz et al, 2010)
- Individuals with diagnosed PTSD will be excluded; there is evidence that those with PTSD may have lower telomere length as compared to those without PTSD (O'Donovan et al, 2011). It is currently unknown how PTSD may impact telomerase levels
- Estrogen use is excluded as it increases telomerase (Lin et al, 2011)
- Smokers will be excluded since smoking decreases telomerase. We will base smoking status on self report. If participants have not smoked regularly for the past 6 months, they will be considered a 'non-smoker
- Pregnant women are excluded since the cell aging system changes during pregnancy in ways that have not been studied
- Participants with a Body Mass Index (BMI) of 35 or greater will be excluded due to differences in telomerase activity in obese women
- Potential eligible participants who are unable to secure the week off from work or other responsibilities will not be enrolled
- Known atrial fibrillation or other chronic dysrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- Harvard Universitycollaborator
- Scripps Translational Science Institutecollaborator
- Duke Universitycollaborator
- Chopra Center for Wellbeingcollaborator
- Mount Sinai Hospital, New Yorkcollaborator
- University of California, San Franciscocollaborator
Study Sites (1)
Chopra Center for Wellbeing
Carlsbad, California, 92009, United States
Study Officials
- STUDY DIRECTOR
Paul J Mills, PHD
University of California, San Diego
- STUDY CHAIR
Rudolph E Tanzi, PhD
Harvard University
- STUDY CHAIR
Deepak Chopra, MD
Chopra Center for Wellbeing & University of California, San Diego
- PRINCIPAL INVESTIGATOR
Elizabeth Blackburn, PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Elissa Epel, PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Sheila Patel, MD
Chopra Center for Wellbeing & University of California, San Diego
- PRINCIPAL INVESTIGATOR
Valencia Porter, MD
Chopra Center for Wellbeing & University of California, San Diego
- PRINCIPAL INVESTIGATOR
Eric Schadt, PhD
MOUNT SINAI HOSPITAL
- PRINCIPAL INVESTIGATOR
Steven Steinhubl, MD
Scripps Translational Science Institute, Scripps Research Institute
- PRINCIPAL INVESTIGATOR
Eric Topel, MD
Scripps Translational Science Institute, Scripps Research Institute
- PRINCIPAL INVESTIGATOR
Murali Doraiswamy, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2014
First Posted
September 16, 2014
Study Start
September 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
December 16, 2015
Record last verified: 2015-12